BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38794334)

  • 1. The Proteasome Inhibitor CEP-18770 Induces Cell Death in Medulloblastoma.
    Nath Varma S; Ye S; Ferlin S; Comer C; Cotton K; Niklison-Chirou MV
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma.
    Frisira E; Rashid F; Varma SN; Badodi S; Benjamin-Ombo VA; Michod D; Niklison-Chirou MV
    Cell Death Dis; 2019 Oct; 10(11):785. PubMed ID: 31619667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
    Piva R; Ruggeri B; Williams M; Costa G; Tamagno I; Ferrero D; Giai V; Coscia M; Peola S; Massaia M; Pezzoni G; Allievi C; Pescalli N; Cassin M; di Giovine S; Nicoli P; de Feudis P; Strepponi I; Roato I; Ferracini R; Bussolati B; Camussi G; Jones-Bolin S; Hunter K; Zhao H; Neri A; Palumbo A; Berkers C; Ovaa H; Bernareggi A; Inghirami G
    Blood; 2008 Mar; 111(5):2765-75. PubMed ID: 18057228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan.
    Sanchez E; Li M; Steinberg JA; Wang C; Shen J; Bonavida B; Li ZW; Chen H; Berenson JR
    Br J Haematol; 2010 Feb; 148(4):569-81. PubMed ID: 19958357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth.
    Ashour AE; Jamal S; Cheryan VT; Muthu M; Zoheir KM; Alafeefy AM; Abd-Allah AR; Levi E; Tarca AL; Polin LA; Rishi AK
    PLoS One; 2013; 8(6):e66733. PubMed ID: 23826121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
    Evans AE; Kisselbach KD; Yamashiro DJ; Ikegaki N; Camoratto AM; Dionne CA; Brodeur GM
    Clin Cancer Res; 1999 Nov; 5(11):3594-602. PubMed ID: 10589776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.
    Wang Y; Rishi AK; Puliyappadamba VT; Sharma S; Yang H; Tarca A; Dou QP; Lonardo F; Ruckdeschel JC; Pass HI; Wali A
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):455-66. PubMed ID: 19960346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
    Chen SM; Li YY; Tu CH; Salazar N; Tseng YY; Huang SF; Hsieh LL; Lui TN
    PLoS One; 2016; 11(8):e0161299. PubMed ID: 27537345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma.
    Vriend J; Ghavami S; Marzban H
    Mol Brain; 2015 Oct; 8(1):64. PubMed ID: 26475605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
    Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
    Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.
    Collins RRJ; Gee RRF; Sanchez MCH; Tozandehjani S; Bayat T; Breznik B; Lee AK; Peters ST; Connelly JP; Pruett-Miller SM; Roussel MF; Rakheja D; Tillman HS; Potts PR; Fon Tacer K
    bioRxiv; 2024 May; ():. PubMed ID: 38798351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer.
    Rohondia SO; Ahmed ZSO; Dou QP
    Curr Cancer Drug Targets; 2020; 20(6):392-409. PubMed ID: 32101123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure.
    Pallavicini G; Iegiani G; Parolisi R; Ferraro A; Garello F; Bitonto V; Terreno E; Gai M; Di Cunto F
    Front Oncol; 2023; 13():1202585. PubMed ID: 37404750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
    Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
    Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.
    Garzia L; Andolfo I; Cusanelli E; Marino N; Petrosino G; De Martino D; Esposito V; Galeone A; Navas L; Esposito S; Gargiulo S; Fattet S; Donofrio V; Cinalli G; Brunetti A; Vecchio LD; Northcott PA; Delattre O; Taylor MD; Iolascon A; Zollo M
    PLoS One; 2009; 4(3):e4998. PubMed ID: 19308264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
    Adile AA; Bakhshinyan D; Suk Y; Uehling D; Saini M; Aman A; Magolan J; Subapanditha MK; McKenna D; Chokshi C; Savage N; Kameda-Smith MM; Venugopal C; Singh SK
    J Neurooncol; 2023 Jul; 163(3):635-645. PubMed ID: 37354357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
    Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
    J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
    Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
    PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label, dose-escalation study to evaluate the safety and pharmacokinetics of CEP-9722 (a PARP-1 and PARP-2 inhibitor) in combination with gemcitabine and cisplatin in patients with advanced solid tumors.
    Awada A; Campone M; Varga A; Aftimos P; Frenel JS; Bahleda R; Gombos A; Bourbouloux E; Soria JC
    Anticancer Drugs; 2016 Apr; 27(4):342-8. PubMed ID: 26796987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.
    Vriend J; Marzban H
    Cell Mol Life Sci; 2017 Feb; 74(3):449-467. PubMed ID: 27592301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.